Thomas Wilder
CIK 1491299 · last filed 2026-02-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.62M
Companies
2
Total Filings
54
Lifetime Open-Market Net
-$1.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PEN | Director | 5,095 | $318.71 | $1.62M | -$979.7K | 35 | 2026-02-18 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Director | 27,864 | — | — | -$854.7K | 18 | 2019-10-01 |
Recent Filings · Page 2 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-05 | PEN | Sell (S) | −124 | -$27.7K | EDGAR |
| 2022-10-05 | PEN | Sell (S) | −124 | -$23.7K | EDGAR |
| 2022-07-06 | PEN | Sell (S) | −248 | -$30.7K | EDGAR |
| 2022-02-23 | PEN | Grant (A) | +710 | $0 | EDGAR |
| 2022-01-05 | PEN | Sell (S) | −80 | -$22.7K | EDGAR |
| 2021-10-05 | PEN | Sell (S) | −80 | -$21.4K | EDGAR |
| 2021-07-14 | PEN | Sell (S) | −161 | -$44.3K | EDGAR |
| 2021-02-23 | PEN | Grant (A) | +535 | $0 | EDGAR |
| 2021-01-06 | PEN | Sell (S) | −115 | -$20.0K | EDGAR |
| 2020-10-05 | PEN | Sell (S) | −115 | -$22.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.